메뉴 건너뛰기
American Journal of Gastroenterology
Volumn 103, Issue 9, 2008, Pages 2410-2412
Onset of ulcerative colitis under treatment with adalimumab
Author keywords

[No Author keywords available]
Indexed keywords

ADALIMUMAB; BECLOMETASONE DIPROPIONATE; MESALAZINE; PROBIOTIC AGENT;
EID: 50649105058     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02010_11.x     Document Type: Letter
Times cited : (7)
References (10)
  • 1
    • 34447102570 scopus 로고    scopus 로고
    • American Gastroenterological Association Consensus Development Conference on the use of biologics in the treatment of inflammatory bowel diseases, June 12-23, 2006
    • AGA Institute.
    • AGA Institute. American Gastroenterological Association Consensus Development Conference on the use of biologics in the treatment of inflammatory bowel diseases, June 12-23, 2006. Gastroenterology 2007 133 : 312 39.
    • (2007) Gastroenterology , vol.133 , pp. 312-39
  • 2
    • 28844473957 scopus 로고    scopus 로고
    • Infliximab for induction and maintenance therapy for ulcerative colitis
    • Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005 353 : 2462 76.
    • (2005) N Engl J Med , vol.353 , pp. 2462-76
    • Rutgeerts, P.1    Sandborn, W.J.2    Feagan, B.G.3
  • 3
    • 0030667544 scopus 로고    scopus 로고
    • Onset of ulcerative colitis during immunosoppressive therapy after liver transplantation
    • Cuoco L, Tursi A, Cammarota G, et al. Onset of ulcerative colitis during immunosoppressive therapy after liver transplantation. Am J Gastroenterol 1997 92 : 2134 5.
    • (1997) Am J Gastroenterol , vol.92 , pp. 2134-5
    • Cuoco, L.1    Tursi, A.2    Cammarota, G.3
  • 4
    • 15244346943 scopus 로고    scopus 로고
    • Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C
    • Khalil A, Lucidarme D, Desurmont P, et al. Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C. Gastroenterol Clin Biol 2005 29 : 193 6.
    • (2005) Gastroenterol Clin Biol , vol.29 , pp. 193-6
    • Khalil, A.1    Lucidarme, D.2    Desurmont, P.3
  • 5
    • 33746692487 scopus 로고    scopus 로고
    • Five cases of de novo inflammatory bowel disease after orthotopic transplantation
    • Wörns MA, Lohrs AW, Neurath MF, et al. Five cases of de novo inflammatory bowel disease after orthotopic transplantation. Am J Gastroenterol 2006 101 : 1931 7.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1931-7
    • Wörns, M.A.1    Lohrs, A.W.2    Neurath, M.F.3
  • 6
    • 34548628636 scopus 로고    scopus 로고
    • Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C.
    • Tursi A. Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C. Inflamm Bowel Dis 2007 13 : 1189 90.
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 1189-90
    • Tursi, A.1
  • 7
    • 36749004359 scopus 로고    scopus 로고
    • Exacerbation of ulcerative colitis after rituximab salvage therapy
    • Goetz M, Atreya R, Ghalibafian M, et al. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 2007 13 : 1365 8.
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 1365-8
    • Goetz, M.1    Atreya, R.2    Ghalibafian, M.3
  • 8
    • 34547543928 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha inhibitor associated ulcerative colitis
    • Prescott K, Costner M, Cohen S, et al. Tumor necrosis factor-alpha inhibitor associated ulcerative colitis. Am J Med Sci 2007 333 : 137 9.
    • (2007) Am J Med Sci , vol.333 , pp. 137-9
    • Prescott, K.1    Costner, M.2    Cohen, S.3
  • 9
    • 33749358799 scopus 로고    scopus 로고
    • Onset of Crohn's disease after Helicobacter pylori eradication
    • Tursi A. Onset of Crohn's disease after Helicobacter pylori eradication. Inflamm Bowel Dis 2006 12 : 1008 9.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 1008-9
    • Tursi, A.1
  • 10
    • 34249857135 scopus 로고    scopus 로고
    • Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: An open-label study
    • Peyrin-Biroulet L, Laclotte C, Roblin X, et al. Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: An open-label study. World J Gastroenterol 2007 13 : 2328 32.
    • (2007) World J Gastroenterol , vol.13 , pp. 2328-32
    • Peyrin-Biroulet, L.1    Laclotte, C.2    Roblin, X.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.